Treatment of Hemiparetic Gait Impairments Using Telehealth With the Moterum iStride Solution™

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

December 19, 2020

Study Completion Date

December 21, 2020

Conditions
TelemedicineGait, HemiplegicGait Disorders, NeurologicStrokeOrthotic DevicesGait Analysis
Interventions
DEVICE

Delivery of iStride™ device gait treatment using telemedicine

The gait device used in this study mimics the actions of the split-belt treadmill but can be used during overground walking and in one's own home, thus enabling long-term training. This device does not require any external power and is completely passive; all necessary forces are redirected from the natural forces present during walking. This research aims to adapt the delivery mechanism of treatment with the iStride™ device to include telemedicine. The telemedicine platform of reference in this study, the Moterum Digital Platform, is an integrated therapeutic platform which offers an activity library, real-time video conferencing, and outcomes tracking. Our primary study objective is to determine if telemedicine is a safe and feasible delivery method for treatment with the iStride ™ gait device.

Trial Locations (1)

84115

Moterum Technologies, Inc. (study location: homes throughout United States), Salt Lake City

Sponsors
All Listed Sponsors
lead

Moterum Technologies, Inc.

INDUSTRY

NCT04434313 - Treatment of Hemiparetic Gait Impairments Using Telehealth With the Moterum iStride Solution™ | Biotech Hunter | Biotech Hunter